Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/26/2019
SMEI: Top Chemical Drug Products in Urban Chinese Retail Pharmacies 20...
8/26/2019
IQVIA: Overall Chinese Pharma Market Growth Slowed to 4.5% in 2018
8/26/2019
Review of Chinese Drug Evaluation and Registration in 2018
8/26/2019
China Adopts New Amendment of PRC Drug Administration Law
8/26/2019
Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
8/23/2019
China Cites Old Data to Support Claim of Higher Birth Rates after Two-...
8/23/2019
Chi-Med Initiates Phase I Trial of HMPL-523 for Immune Thrombocytopeni...
8/23/2019
New Revision Draft of Drug Administration Law Submitted to the NPC for...
8/23/2019
111 Signs Strategic Partnership with TK.CN to Empower PBM and Insuranc...
8/23/2019
China to Step Up Crackdown on Drug Monopoly to Keep Prices and Supply ...
8/22/2019
CDE Publicizes 16 Drug Applications To Be Granted Priority Review Stat...
8/22/2019
Luye Pharma to Begin Trials of Anti-depression Drug in Japan as It Pro...
8/21/2019
Upcoming Event: Asia Biopharma Continuous Manufacturing & Process ...
8/21/2019
Study links pollution to increase in bipolar disorder, depression
8/21/2019
Roxadustat Approved in China for Treatment of Anemia in CKD Patients N...
8/21/2019
China's Biopharma Strategy: Challenge or Complement to U.S. Industry C...
8/21/2019
Innovent Enters a Licensing Agreement with Lilly to Develop & ...
8/21/2019
Alligator Bio and Biotheus Enter Antibody Agreement for Greater China
8/21/2019
Cancer Research Facilities Become A Target of Chinese Hackers
8/21/2019
USFDA Grants Priority Review to BeiGene's Zanubrutinib in Patients wit...
8/21/2019
Roche Granted Additional Indication for Its Breast Cancer Drug Perjeta
8/21/2019
CDE Accepts Clinical Trial Application of Gilead's NASH drug Selonsert...
8/21/2019
Cancer Treatment in China: The Underestimated Opportunity
8/21/2019
CMAB and Kintor Announce a New Partnership to Develop and Manufacture ...
8/20/2019
China's Central Government Introduces Major Policy Incentives and Rest...
8/20/2019
NHSA and MOHRSS Issue NRDL under the BMI, WRI and Maternity Insurance
8/20/2019
Chronic and Aging-related Diseases Cost Over Half of Chinese BMI Spend...
8/19/2019
NMPA Issues the Administrative Measures for Drug Quality Sampling Insp...
8/19/2019
CitiResearch - China at Inflection Point: Big Opportunity for MNCs, Do...
8/19/2019
Sanofi Gains Chinese IND Approval for RNAi Therapy Fitusiran Injection
Page:
270
/
775
Total number of articles:
23233
:
[First]
[<<]
[268]
[269]
[270]
[271]
[272]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit